相关实验视频
Updated: Sep 14, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
用抗糖尿病和抗肥胖药物预防和拦截癌症:当前和未来的前景
Adriana Albini1, Anna Rita Cantelmo2, Lorenzo Mortara3
1Scientific Directorate, European Institute of Oncology IEO, IRCCS, Milan, Italy.
某些糖尿病和肥胖药物可以通过向代谢健康来帮助预防癌症. 甲胺显示抗癌性质,而GLP-1激动剂和SGLT2抑制剂提供新兴的好处,尽管需要更多的研究.
科学领域:
- 代谢健康和瘤学
- 用于预防癌症的药理干预措施
背景情况:
- 肥胖和2型糖尿病是心血管疾病和各种癌症的重要危险因素,包括肝癌,胰腺癌,子宫内膜癌和乳腺癌.
- 慢性高胰岛素血症,全身炎症和与肥胖相关的代谢失调创造了一个促进瘤的环境.
研究的目的:
- 审查抗糖尿病和抗肥胖药物的潜在癌症预防作用.
- 总结关于这些药物的癌症预防机制和疗效的临床前和临床证据.
主要方法:
- 关于抗糖尿病和抗肥胖药物的当前临床前和临床证据的审查.
- 拟议的抗癌机制的摘要,包括AMP激活蛋白激酶激活,mTOR抑制和IGF-1信号调节.
主要成果:
- 甲胺通过多个信号通路显示出抗癌性质.
- 类似葡萄糖类-1受体激动剂 (例如,西马格卢提德,提泽帕提德) 通过减肥,改善胰岛素敏感性和抗炎作用显示出有前途.
- -葡萄糖共运输体2抑制剂可以通过减少葡萄糖的可用性和炎症来抑制瘤.
结论:
- 观察数据表明,某些抗糖尿病和抗肥胖药物可能会降低癌症风险,但可靠的临床试验有限.
- 进一步的研究,包括大规模试验,对于验证这些药物的瘤益处和风险至关重要.
- 长期的安全性和在特定情况下的潜在瘤促进作用需要进行彻底的调查.
更多相关视频
02:55Author Spotlight: Illuminating New Avenues for Adipose Tissue Metabolism and Disease Prevention
Published on: October 6, 2023
13:09Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet
Published on: July 31, 2021
相关概念视频
Cancer Prevention
Some...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Psychoneuroimmunology: Diabetes and Cancer
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...